Direkt zum Inhalt

Vettermann, Franziska J. ; Diekmann, Caroline ; Weidner, Lorraine ; Unterrainer, Marcus ; Suchorska, Bogdana ; Ruf, Viktoria ; Dorostkar, Mario ; Wenter, Vera ; Herms, Jochen ; Tonn, Jörg-Christian ; Bartenstein, Peter ; Riemenschneider, Markus J. ; Albert, Nathalie L.

L-type amino acid transporter (LAT) 1 expression in 18F-FET-negative gliomas

Vettermann, Franziska J., Diekmann, Caroline, Weidner, Lorraine, Unterrainer, Marcus, Suchorska, Bogdana, Ruf, Viktoria, Dorostkar, Mario, Wenter, Vera, Herms, Jochen, Tonn, Jörg-Christian, Bartenstein, Peter, Riemenschneider, Markus J. und Albert, Nathalie L. (2021) L-type amino acid transporter (LAT) 1 expression in 18F-FET-negative gliomas. EJNMMI Research 11 (1).

Veröffentlichungsdatum dieses Volltextes: 29 Feb 2024 12:28
Artikel
DOI zum Zitieren dieses Dokuments: 10.5283/epub.56456


Zusammenfassung

Background O-(2-[18F]-fluoroethyl)-L-tyrosine (18F-FET) is a highly sensitive PET tracer for glioma imaging, and its uptake is suggested to be driven by an overexpression of the L-type amino-acid transporter 1 (LAT1). However, 30% of low- and 5% of high-grade gliomas do not present enhanced 18F-FET uptake at primary diagnosis (“18F-FET-negative gliomas”) and the pathophysiologic basis for this ...

Background
O-(2-[18F]-fluoroethyl)-L-tyrosine (18F-FET) is a highly sensitive PET tracer for glioma imaging, and its uptake is suggested to be driven by an overexpression of the L-type amino-acid transporter 1 (LAT1). However, 30% of low- and 5% of high-grade gliomas do not present enhanced 18F-FET uptake at primary diagnosis (“18F-FET-negative gliomas”) and the pathophysiologic basis for this phenomenon remains unclear. The aim of this study was to determine the expression of LAT1 in a homogeneous group of newly diagnosed 18F-FET-negative gliomas and to compare them to a matched group of 18F-FET-positive gliomas. Forty newly diagnosed IDH-mutant astrocytomas without 1p/19q codeletion were evaluated (n = 20 18F-FET-negative (tumour-to-background ratio (TBR) < 1.6), n = 20 18F-FET-positive gliomas (TBR > 1.6)). LAT1 immunohistochemistry (IHC) was performed using SLC7A5/LAT1 antibody. The percentage of LAT1-positive tumour cells (%) and the staining intensity (range 0–2) were multiplied to an overall score (H-score; range 0–200) and correlated to PET findings as well as progression-free survival (PFS).

Results
IHC staining of LAT1 expression was positive in both, 18F-FET-positive as well as 18F-FET-negative gliomas. No differences were found between the 18F-FET-negative and 18F-FET-positive group with regard to percentage of LAT1-positive tumour cells, staining intensity or H-score. Interestingly, the LAT1 expression showed a significant negative correlation with the PFS (p = 0.031), whereas no significant correlation was found for TBRmax, neither in the overall group nor in the 18F-FET-positive group only (p = 0.651 and p = 0.140).

Conclusion
Although LAT1 is reported to mediate the uptake of 18F-FET into tumour cells, the levels of LAT1 expression do not correlate with the levels of 18F-FET uptake in IDH-mutant astrocytomas. In particular, the lack of tracer uptake in 18F-FET-negative gliomas cannot be explained by a reduced LAT1 expression. A higher LAT1 expression in IDH-mutant astrocytomas seems to be associated with a short PFS. Further studies regarding mechanisms influencing the uptake of 18F-FET are necessary.



Beteiligte Einrichtungen


Details

DokumentenartArtikel
Titel eines Journals oder einer ZeitschriftEJNMMI Research
Verlag:Springer
Ort der Veröffentlichung:NEW YORK
Band:11
Nummer des Zeitschriftenheftes oder des Kapitels:1
Datum14 Dezember 2021
InstitutionenMedizin > Abteilung für Neuropathologie
Identifikationsnummer
WertTyp
10.1186/s13550-021-00865-9DOI
Stichwörter / KeywordsCENTRAL-NERVOUS-SYSTEM; DYNAMIC F-18-FET PET; LOW-GRADE GLIOMA; RESPONSE ASSESSMENT; PROGNOSTIC-SIGNIFICANCE; LUNG; C-11-METHIONINE; NEUROONCOLOGY; ADENOCARCINOMA; ASCT2; LAT1; FET PET; Glioma; Molecular imaging
Dewey-Dezimal-Klassifikation600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin
StatusVeröffentlicht
BegutachtetJa, diese Version wurde begutachtet
An der Universität Regensburg entstandenJa
URN der UB Regensburgurn:nbn:de:bvb:355-epub-564563
Dokumenten-ID56456

Bibliographische Daten exportieren

Nur für Besitzer und Autoren: Kontrollseite des Eintrags

nach oben